GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Spago Nanomedical AB (OSTO:SPAGO) » Definitions » Shiller PE Ratio

Spago Nanomedical AB (OSTO:SPAGO) Shiller PE Ratio : (As of Jun. 19, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Spago Nanomedical AB Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Spago Nanomedical AB Shiller PE Ratio Historical Data

The historical data trend for Spago Nanomedical AB's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spago Nanomedical AB Shiller PE Ratio Chart

Spago Nanomedical AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Spago Nanomedical AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Spago Nanomedical AB's Shiller PE Ratio

For the Biotechnology subindustry, Spago Nanomedical AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Spago Nanomedical AB's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Spago Nanomedical AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Spago Nanomedical AB's Shiller PE Ratio falls into.



Spago Nanomedical AB Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Spago Nanomedical AB's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Spago Nanomedical AB's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.03/132.2054*132.2054
=-0.030

Current CPI (Mar. 2024) = 132.2054.

Spago Nanomedical AB Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.259 100.432 -0.341
201409 -0.135 100.161 -0.178
201412 -0.377 100.225 -0.497
201503 -0.322 99.950 -0.426
201506 -0.280 99.995 -0.370
201509 -0.195 100.228 -0.257
201512 -0.140 100.276 -0.185
201603 -0.239 100.751 -0.314
201606 -0.207 101.019 -0.271
201609 -0.127 101.138 -0.166
201612 -0.187 102.022 -0.242
201703 -0.214 102.022 -0.277
201706 -0.243 102.752 -0.313
201709 -0.189 103.279 -0.242
201712 -0.214 103.793 -0.273
201803 -0.152 103.962 -0.193
201806 -0.181 104.875 -0.228
201809 -0.125 105.679 -0.156
201812 -0.178 105.912 -0.222
201903 -0.241 105.886 -0.301
201906 -0.206 106.742 -0.255
201909 -0.225 107.214 -0.277
201912 -0.272 107.766 -0.334
202003 -0.226 106.563 -0.280
202006 -0.179 107.498 -0.220
202009 -0.132 107.635 -0.162
202012 -0.132 108.296 -0.161
202103 -0.170 108.360 -0.207
202106 -0.267 108.928 -0.324
202109 -0.248 110.338 -0.297
202112 -0.306 112.486 -0.360
202203 -0.229 114.825 -0.264
202206 -0.220 118.384 -0.246
202209 -0.105 122.296 -0.114
202212 -0.096 126.365 -0.100
202303 -0.170 127.042 -0.177
202306 -0.086 129.407 -0.088
202309 -0.076 130.224 -0.077
202312 -0.124 131.912 -0.124
202403 -0.030 132.205 -0.030

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Spago Nanomedical AB  (OSTO:SPAGO) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Spago Nanomedical AB Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Spago Nanomedical AB's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Spago Nanomedical AB (OSTO:SPAGO) Business Description

Traded in Other Exchanges
Address
Scheelevagen 22, Lund, SWE, SE-223 63
Spago Nanomedical AB is a nanomedicine company in the field of cancer diagnosis and treatment. The company's product includes SpagoPix and Tumorad. The SpagoPix product aims to improve cancer diagnosis with magnetic resonance imaging through previous detection of tumors and metastases. The Tumorad products focuses on the development of a completely new form of radionuclide therapy for tumor selective radiation therapy of cancer. The company development projects are based on a platform of polymeric materials with varoious properties for precise diagnosis and treatment of life threatening and debilitating diseases.

Spago Nanomedical AB (OSTO:SPAGO) Headlines

No Headlines